Otsuka Pharmaceutical to Ship Antipsychotic Agent.Tokyo, Japan, June 7, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Otsuka Pharmaceutical announced on June 6 that it will begin shipping Abilify, its proprietary antipsychotic agent antipsychotic agent Major tranquilizer, neuroleptic Neuropharmacology Any drug that attenuates psychotic episodes Agents Phenothiazines, thioxanthenes, butyrophenones, dibenzoxazepines, dibenzodiazepines, diphenylbutylpiperidines Indications Management of , in Japan on June 8. Abilify (aripiprazole), a dopamine dopamine (dōp`əmēn), one of the intermediate substances in the biosynthesis of epinephrine and norepinephrine. See catecholamine. dopamine One of the catecholamines, widely distributed in the central nervous system. partial agonist, which has a different action mechanism from the conventional antipsychotics Antipsychotics A class of drugs used to control psychotic symptoms in patients with psychotic disorders such as schizophrenia and delusional disorder. Antipsychotics include risperidone (Risperdal), haloperidol (Haldol), and chlorpromazine (Thorazine). , is a new option for schizophrenia. Initially approved in the US in November 2002, Abilify is currently available in over 45 countries worldwide. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion